BIORRO

Industry

Feed, Food ingredients, Industrial chemistry, Seeds & genetics

Topics

Enzymes & biocatalysis, Livestock & poultry production/genetics, Probiotics & cultures, Animal feed & feed additives

Role

Services / consulting — “…ed biotechnology solutions, consulting, implementation of efficient technologies for businesses; emphasis on t…”

Why it is bioeconomy

BIORRO is a biotechnology company that supplies enzyme products, probiotics, and feed additives for agriculture and industrial applications.

Found via

AB Enzymes; Bioagra; [Rubric] Estonia · feed-additives; [Rubric] Estonia · inoculants

Not yet cited as a supplier in a graded solution.

• 2026-05 Latest status: The company's registration address was updated on May 27, 2026, and its manager was changed on April 11, 2024. ↗ ↗ ↗
• Status review: active — Hosted Cosun Protein for talks on a faba-bean protein plant in Lithuania (2025-07).
• 2025-07-09 Field visit and business talks with Cosun Protein.Strategic partnerships grow from the ground up 🌱 | Mindaugas Lazdauskas
  BIORRO, represented by Mindaugas Lazdauskas, hosted Cosun Protein for field visits and talks about a potential €75–100 million wet faba bean protein isolate facility in Lithuania, signaling active collaboration and potential growth in the local pulse farming …
• 2025-11-27 Kartu su kolegomis iš Panevėžio aruodas komandos šiandien dalyvavome Agroverslas 2025 konferencijoje, daug realių įžvalgų, tiesiai iš sektoriaus lyderių. | Mindaugas Lazdauskas
  BIORRO is represented by Mindaugas Lazdauskas, who serves on the Management Board (2 years 6 months in that role) and previously was CEO; he is based in Kaunas, Lithuania.
• 2026-09-03 €61 Million Cell Therapy Center Opens in Vilnius — Another Step in the “Bio City” Vision – LithuaniaBIO
  BIORRO is not mentioned in the article. The piece focuses on the €61 million Cell Therapy Center in Vilnius as part of the Bio City III project, its capabilities (cell therapy, personalized vaccines, regenerative medicine, 3D-printed tissues), expected 100 …
• 2026-09-03 Lithuania Opens €61 Million BIO CITY III Cell Therapy Centre | Lithuania
  BIORRO is not mentioned in the article. The piece focuses on Lithuania inaugurating the €61 million BIO CITY III cell therapy and personalised medicine centre in Vilnius, its capabilities (20 GMP-compliant production lines, 3,500 sq m, CAR-T and 3D tissue …
• 2026-09-23 Lithuania’s biotech ecosystem is moving from research towards scale, with companies working across the value chain – from AI-powered protein design and single-cell analysis to CRISPR, advanced therapies and precision fermentation.
  Summary: The article highlights Lithuania’s biotech shift from research to scalable industry, profiling five companies (Biomatter, Atrandi Biosciences, Caszyme, Northway Biotech, and Pentasweet) as examples of the broader ecosystem; BIORRO is not mentioned in …
• 2026-09-03 Lithuania is no longer just a consumer of global life sciences innovation. We're becoming its creators. 🧬
  BIORRO isn’t mentioned in this post. The update highlights Lithuania’s shift from consumer to creator in life sciences, celebrating the opening of BIO CITY III and the country’s biotech talent and ambition.

Ownership & investors 1

Similar companies

c-LEcta GmbH · AB Enzymes · Enzym Group · BIO-GEN · Solyve · Fermentia Ltd. · Leiber GmbH · INTERMAG